Blog.

The Senate HELP Committee discussion draft would define the 340B patient institute, codify contract pharmacy rights, let manufacturers elect rebates, and cap TPA and pharmacy fees. The Committee accepts comments through August 28, 2026.

The proposed CY 2027 outpatient payment rule would cut 340B drug reimbursement by nearly 40 percentage points, speed up an existing $7.8 billion clawback, and extend site-neutral payment to imaging. CMS will accept comments through August 31, 2026.